IL-32 exacerbates adenoid hypertrophy via activating NLRP3-mediated cell pyroptosis, which promotes inflammation

Zhang,Junmei; Sun,Xuyuan; Zhong,Lingling; Shen,Bei

doi:10.3892/mmr.2021.11865

IL-32 exacerbates adenoid hypertrophy via activating NLRP3-mediated cell pyroptosis, which promotes inflammation

Authors:
- Junmei Zhang
- Xuyuan Sun
- Lingling Zhong
- Bei Shen
View Affiliations

Affiliations: Department of Otolaryngology, Tianjin Children's Hospital, Tianjin 300134, P.R. China
Published online on: January 24, 2021 https://doi.org/10.3892/mmr.2021.11865
Article Number: 226
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adenoid hypertrophy (AH) is a common pediatric disease caused by inflammatory stimulation. The pro-inflammatory cytokine IL-32 has been reported to promote airway inflammation and also be involved in the pyroptosis pathway. However, whether IL-32 can contribute to AH by mediating pyroptosis remains to be elucidated. The present study aimed to investigate the role of IL-32 in AH and determine the potential underlying mechanisms. Adenoid tissues were collected from healthy children and children with AH, and the expression of IL-32, NACHT LRR and PYD domains-containing protein 3 (NLRP3) and IL-1β in normal and hypertrophic tissues were measured. Human nasal epithelial cells (HNEpCs) were exposed to a series of IL-32 concentrations. HNEpCs with or without IL-32 silencing were stimulated with lipopolysaccharide (LPS), and cell proliferation, cell apoptosis, gasdermin D (GSDMD) activation, production of inflammatory cytokines and the expression levels of proteins related to the potential mechanisms were evaluated by Cell Counting Kit-8, flow cytometry, immunofluorescence staining, ELISA and western blot assays, respectively. The results showed that IL-32, NLRP3 and IL-1β exhibited higher expression in adenoid tissues with AH compared with normal tissues. In HNEpC cells, treatment with IL-32 (2 and 10 ng/ml) promoted cell proliferation, while 50 ng/ml IL-32 inhibited cell proliferation at 12, 24 and 48 h post-treatment. IL-32 (2, 10 and 50 ng/ml) also resulted in differing degrees of apoptosis, GSDMD activation, release of IL-1β, IL-6 and TNF-α, and increased protein expression levels of NLRP3, cleaved-caspase-1, activated GSDMD, nucleotide-binding oligomerization domain-containing protein (NOD) 1/2 and Toll-like receptor (TLR)4 in a concentration-dependent manner. In addition, compared with the LPS group, IL-32 knockdown significantly inhibited LPS-induced enhancement of cell proliferation, cell apoptosis, GSDMD activation and production of inflammatory cytokines, and reversed the increased protein expression of NLRP3, cleaved-caspase-1, activated GSDMD, NOD1/2 and TLR4. In conclusion, IL-32 may play a role in the progression of AH via promoting inflammation, and the potential mechanism may involve the activation of NLRP3-mediated pyroptosis.

View Figures

View References

1	Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A, Haigentz M Jr, Takes RP, et al: Adenoid cystic carcinoma of the head and neck - An update. Oral Oncol. 51:652–661. 2015. View Article : Google Scholar : PubMed/NCBI
2	Buzatto GP, Tamashiro E, Proenca-Modena JL, Saturn TH, Prates MC, Gagliardi TB, Carenzi LR, Massuda ET, Hyppolito MA, Valera FC, et al: The pathogens profile in children with otitis media with effusion and adenoid hypertrophy. PLoS One. 12:e01710492017. View Article : Google Scholar : PubMed/NCBI
3	Durgut O and Dikici O: The effect of adenoid hypertrophy on hearing thresholds in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 124:116–119. 2019. View Article : Google Scholar : PubMed/NCBI
4	Stupak HD and Park SY: Gravitational forces, negative pressure and facial structure in the genesis of airway dysfunction during sleep: A review of the paradigm. Sleep Med. 51:125–132. 2018. View Article : Google Scholar : PubMed/NCBI
5	Scadding G: Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol. 21:1095–1106. 2010. View Article : Google Scholar : PubMed/NCBI
6	Gulotta G, Iannella G, Vicini C, Polimeni A, Greco A, de Vincentiis M, Visconti IC, Meccariello G, Cammaroto G, De Vito A, et al: Risk factors for obstructive sleep apnea syndrome in children. Int J Environ Res Public Health. 16:32352019. View Article : Google Scholar
7	Marazzato M, Zicari AM, Aleandri M, Conte AL, Longhi C, Vitanza L, Bolognino V, Zagaglia C, De Castro G, Brindisi G, et al: 16S metagenomics reveals dysbiosis of nasal core microbiota in children with chronic nasal inflammation: Role of adenoid hypertrophy and allergic rhinitis. Front Cell Infect Microbiol. 10:4582020. View Article : Google Scholar : PubMed/NCBI
8	Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH and Park MH: Interleukin 32, inflammation and cancer. Pharmacol Ther. 174:127–137. 2017. View Article : Google Scholar : PubMed/NCBI
9	Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS and Kim HM: IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol. 224:553–563. 2011. View Article : Google Scholar : PubMed/NCBI
10	Nam SY, Oh HA, Choi Y, Park KY, Kim HM and Jeong HJ: Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis. J Med Food. 17:939–948. 2014. View Article : Google Scholar : PubMed/NCBI
11	Jeong HJ, Oh HA, Lee BJ and Kim HM: Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium). Int J Mol Med. 33:142–150. 2014. View Article : Google Scholar : PubMed/NCBI
12	Keswani A, Kern RC, Schleimer RP and Kato A: Role of interleukin-32 in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 13:13–18. 2013. View Article : Google Scholar : PubMed/NCBI
13	Kim SH, Han SY, Azam T, Yoon DY and Dinarello CA: Interleukin-32: A cytokine and inducer of TNFalpha. Immunity. 22:131–142. 2005. View Article : Google Scholar : PubMed/NCBI
14	Pan X, Cao H, Lu J, Shu X, Xiong X, Hong X, Xu Q, Zhu H, Li G and Shen G: Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB. Mol Immunol. 48:1573–1577. 2011. View Article : Google Scholar : PubMed/NCBI
15	Lu J, Fang K, Wang S, Xiong L, Zhang C, Liu Z, Guan X, Zheng R, Wang G, Zheng J, et al: Anti-inflammatory effect of columbianetin on lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Mediators Inflamm. 2018:91917432018. View Article : Google Scholar : PubMed/NCBI
16	Wang S, Yuan YH, Chen NH and Wang HB: The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease. Int Immunopharmacol. 67:458–464. 2019. View Article : Google Scholar : PubMed/NCBI
17	Yang Z, Liang C, Wang T, Zou Q, Zhou M, Cheng Y, Peng H, Ji Z, Deng Y, Liao J, et al: NLRP3 inflammasome activation promotes the development of allergic rhinitis via epithelium pyroptosis. Biochem Biophys Res Commun. 522:61–67. 2020. View Article : Google Scholar : PubMed/NCBI
18	Hu H and Li H: Prunetin inhibits lipopolysaccharide-induced inflammatory cytokine production and MUC5AC expression by inactivating the TLR4/MyD88 pathway in human nasal epithelial cells. Biomed Pharmacother. 106:1469–1477. 2018. View Article : Google Scholar : PubMed/NCBI
19	Tsou YA, Tung YT, Wu TF, Chang GRL, Chen HC, Lin CD, Lai CH, Chen HL and Chen CM: Lactoferrin interacts with SPLUNC1 to attenuate lipopolysaccharide-induced inflammation of human nasal epithelial cells via down-regulated MEK1/2-MAPK signaling. Biochem Cell Biol. 95:394–399. 2017. View Article : Google Scholar : PubMed/NCBI
20	Li YQ, Zhong Y, Xiao XP, Li DD, Zhou Z and Tian YY: IL-33/ST2 axis promotes the inflammatory response of nasal mucosal epithelial cells through inducing the ERK1/2 pathway. Innate Immun. 26:505–513. 2020. View Article : Google Scholar : PubMed/NCBI
21	Nian JB, Zeng M, Zheng J, Zeng LY, Fu Z, Huang QJ and Wei X: Epithelial cells expressed IL-33 to promote degranulation of mast cells through inhibition on ST2/PI3K/mTOR-mediated autophagy in allergic rhinitis. Cell Cycle. 19:1132–1142. 2020. View Article : Google Scholar : PubMed/NCBI
22	Lin J, Xu R, Hu L, You J, Jiang N, Li C, Che C, Wang Q, Xu Q, Li J, et al: Interleukin-32 induced thymic stromal lymphopoietin plays a critical role in the inflammatory response in human corneal epithelium. Cell Signal. 49:39–45. 2018. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Kiraly O, Gong G, Olipitz W, Muthupalani S and Engelward BP: Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet. 11:e10049012015. View Article : Google Scholar : PubMed/NCBI
25	Anfuso A, Ramadan H, Terrell A, Demirdag Y, Walton C, Skoner DP and Piedimonte G: Sinus and adenoid inflammation in children with chronic rhinosinusitis and asthma. Ann Allergy Asthma Immunol. 114:103–110. 2015. View Article : Google Scholar : PubMed/NCBI
26	Sun YL, Zheng HT, Tao JL, Jiang MC, Hu CC, Li XM and Yuan B: Effectiveness and safety of Chinese herbal medicine for pediatric adenoid hypertrophy: A meta-analysis. Int J Pediatr Otorhinolaryngol. 119:79–85. 2019. View Article : Google Scholar : PubMed/NCBI
27	Richter GT and Bower CM: Cervical complications following routine tonsillectomy and adenoidectomy. Curr Opin Otolaryngol Head Neck Surg. 14:375–380. 2006. View Article : Google Scholar : PubMed/NCBI
28	van den Akker EH, Sanders EA, van Staaij BK, Rijkers GT, Rovers MM, Hoes AW and Schilder AG: Long-term effects of pediatric adenotonsillectomy on serum immunoglobulin levels: Results of a randomized controlled trial. Ann Allergy Asthma Immunol. 97:251–256. 2006. View Article : Google Scholar : PubMed/NCBI
29	Rogala B and Glück J: The role of interleukin-33 in rhinitis. Curr Allergy Asthma Rep. 13:196–202. 2013. View Article : Google Scholar : PubMed/NCBI
30	Kim DK, Jin HR, Eun KM, Mo JH, Cho SH, Oh S, Cho D and Kim DW: The role of interleukin-33 in chronic rhinosinusitis. Thorax. 72:635–645. 2017. View Article : Google Scholar : PubMed/NCBI
31	Luo XQ, Ma F, Wang S, Zhao MZ, Shao JB, Geng XR, Liu JQ, Mo LH, Guan L, Liu ZG, et al: Interleukin-5 induces apoptotic defects in CD4⁺ T cells of patients with allergic rhinitis. J Leukoc Biol. 105:719–727. 2019. View Article : Google Scholar : PubMed/NCBI
32	Huang CC, Wu PW, Chen CL, Wang CH, Lee TJ, Tsai CN and Chiu CH: IL-17A expression in the adenoid tissue from children with sleep disordered breathing and its association with pneumococcal carriage. Sci Rep. 8:167702018. View Article : Google Scholar : PubMed/NCBI
33	Bergsbaken T, Fink SL and Cookson BT: Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol. 7:99–109. 2009. View Article : Google Scholar : PubMed/NCBI
34	Keestra-Gounder AM, Byndloss MX, Seyffert N, Young BM, Chávez-Arroyo A, Tsai AY, Cevallos SA, Winter MG, Pham OH, Tiffany CR, et al: NOD1 and NOD2 signalling links ER stress with inflammation. Nature. 532:394–397. 2016. View Article : Google Scholar : PubMed/NCBI
35	Di Stefano A, Ricciardolo FLM, Caramori G, Adcock IM, Chung KF, Barnes PJ, Brun P, Leonardi A, Andò F, Vallese D, et al: Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. Eur Respir J. 49:16020062017. View Article : Google Scholar : PubMed/NCBI
36	Luo M, Yan D, Sun Q, Tao J, Xu L, Sun H and Zhao H: Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-κB/NLRP3 pathway. J Cell Biochem. 121:2994–3004. 2020. View Article : Google Scholar : PubMed/NCBI
37	Aabdin ZU, Bilal MS, Dai H, Abaker JA, Liu X, Benazir S, Yan J and Shen X: NOD1/NF-κB signaling pathway inhibited by sodium butyrate in the mammary gland of lactating goats during sub-acute ruminal acidosis. Microb Pathog. 122:58–62. 2018. View Article : Google Scholar : PubMed/NCBI